Jerome Deval

This inventor holds 30 USPTO granted patents and 14 published patent applications, plus 5 CIPO patents and 9 EPO patents, primarily in Nucleotide Analog Chemistry. Top assignees: Alios Biopharma, Inc., Aligos Therapeutics, Inc., Janssen Biopharma, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jerome Deval. Retrieved from https://idiyas.com/inventor/jerome-deval

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 14)

% Patents Active = 63.3

CIPO Patents = 5 (Patent Applications = 15)

EPO Patents = 9 (Patent Applications = 23)

Average Co-Inventor Count = 4.7

ph-index = 10

Forward Citations = 424(Granted Patents)

Location History:

Pacifica, CA (US) (2014 - 2024)
El Granada, CA (US) (2021 - 2024)

Company Filing History:

13 out of 44

Alios Biopharma, Inc.

patents

12 out of 38

Aligos Therapeutics, Inc.

patents

4 out of 22

Janssen Biopharma, Inc.

patents

4. 1 out of 161

Janssen Pharmaceuticals, Inc.

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Pyridazinone

PD-L1

THR-β Modulators

Nucleosides

Nucleotide Analogs

Oxindoles

Bicyclic Compounds

Cyclic Nucleotide Analogs

Substituted Nucleotides

PRMT5 Compounds

Compositions

Methods of Use

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630537 - Pyridazinone and methods of use thereof (2026-05-19),

2. 12534450 - Methods and compositions for targeting PD-L1 (2026-01-27),

3. 12180192 - Modulators of THR-β and methods of use thereof (2024-12-31),

4. 12018015 - Methods and compositions for targeting PD-L1 (2024-06-25),

5. 11858913 - Bicyclic pyridazinones and methods of use thereof (2024-01-02),

6. 11840532 - Modulators of THR-β and methods of use thereof (2023-12-12),

7. 11793815 - Oxindoles and methods of use thereof (2023-10-24),

8. 11786532 - 2-pyridones and methods of use thereof (2023-10-17),

9. 11773126 - Substituted nucleosides, nucleotides and analogs thereof (2023-10-03),

10. 11760764 - Methods and compositions for targeting PD-L1 (2023-09-19),

11. 11760761 - Methods and compositions for targeting PD-L1 (2023-09-19),

12. 11198699 - Compounds targeting PRMT5 (2021-12-14),

13. 11149049 - Substituted nucleosides, nucleotides and analogs thereof (2021-10-19),

14. 11091467 - Modulators of THR-β and methods of use thereof (2021-08-17),

15. 11021509 - Substituted nucleosides, nucleotides and analogs thereof (2021-06-01),

Title: The Innovative Journey of Jerome Deval

Introduction: Jerome Deval, a talented inventor hailing from Pacifica, CA (US), has made significant contributions to the world of innovations with his creative mind and dedication.

Latest Patents: Jerome Deval holds several patents in various fields, showcasing his versatility and expertise in inventing groundbreaking solutions to complex problems.

Career Highlights: Throughout his career, Jerome Deval has demonstrated a keen eye for identifying gaps in the market and developing unique inventions to fill those voids. His passion for innovation has led to the creation of several successful products that have improved the lives of many.

Collaborations: Jerome Deval has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Jerome Deval's journey as an inventor is a testament to his unwavering commitment to pushing the boundaries of what is possible through innovation. His impact on the world of inventions is truly remarkable, and his legacy will continue to inspire future generations of inventors.

Profile summary based on public USPTO records.